Jozef Madzo to Carcinoma, Transitional Cell
This is a "connection" page, showing publications Jozef Madzo has written about Carcinoma, Transitional Cell.
Connection Strength
0.202
-
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy. Clin Cancer Res. 2023 06 01; 29(11):2052-2065.
Score: 0.202